Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article

Advertisement

ResearchIn-Press PreviewCell biologyOncology Open Access | 10.1172/JCI186711

MRE11 deacetylation by SIRT2 promotes DNA binding to facilitate DNA end resection and ATM-dependent signaling

Fatmata Sesay,1 Hui Zhang,1 Priya Kapoor-Vazirani,1 Andrew T. Jung,1 Mark E. Essien,1 Amanda J. Bastien,1 Nho C. Luong,1 Xu Liu,2 PamelaSara E. Head,1 Duc M. Duong,2 Xiaofeng Yang,1 Zachary S. Buchwald,1 Xingming Deng,1 Nicholas T. Seyfried,2 and David S. Yu1

1Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, United States of America

2Department of Biochemistry, Emory University School of Medicine, Atlanta, United States of America

Find articles by Sesay, F. in: PubMed | Google Scholar

1Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, United States of America

2Department of Biochemistry, Emory University School of Medicine, Atlanta, United States of America

Find articles by Zhang, H. in: PubMed | Google Scholar

1Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, United States of America

2Department of Biochemistry, Emory University School of Medicine, Atlanta, United States of America

Find articles by Kapoor-Vazirani, P. in: PubMed | Google Scholar

1Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, United States of America

2Department of Biochemistry, Emory University School of Medicine, Atlanta, United States of America

Find articles by Jung, A. in: PubMed | Google Scholar

1Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, United States of America

2Department of Biochemistry, Emory University School of Medicine, Atlanta, United States of America

Find articles by Essien, M. in: PubMed | Google Scholar

1Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, United States of America

2Department of Biochemistry, Emory University School of Medicine, Atlanta, United States of America

Find articles by Bastien, A. in: PubMed | Google Scholar

1Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, United States of America

2Department of Biochemistry, Emory University School of Medicine, Atlanta, United States of America

Find articles by Luong, N. in: PubMed | Google Scholar

1Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, United States of America

2Department of Biochemistry, Emory University School of Medicine, Atlanta, United States of America

Find articles by Liu, X. in: PubMed | Google Scholar

1Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, United States of America

2Department of Biochemistry, Emory University School of Medicine, Atlanta, United States of America

Find articles by Head, P. in: PubMed | Google Scholar

1Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, United States of America

2Department of Biochemistry, Emory University School of Medicine, Atlanta, United States of America

Find articles by Duong, D. in: PubMed | Google Scholar

1Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, United States of America

2Department of Biochemistry, Emory University School of Medicine, Atlanta, United States of America

Find articles by Yang, X. in: PubMed | Google Scholar

1Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, United States of America

2Department of Biochemistry, Emory University School of Medicine, Atlanta, United States of America

Find articles by Buchwald, Z. in: PubMed | Google Scholar

1Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, United States of America

2Department of Biochemistry, Emory University School of Medicine, Atlanta, United States of America

Find articles by Deng, X. in: PubMed | Google Scholar

1Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, United States of America

2Department of Biochemistry, Emory University School of Medicine, Atlanta, United States of America

Find articles by Seyfried, N. in: PubMed | Google Scholar

1Department of Radiation Oncology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, United States of America

2Department of Biochemistry, Emory University School of Medicine, Atlanta, United States of America

Find articles by Yu, D. in: PubMed | Google Scholar

Published January 8, 2026 - More info

J Clin Invest. https://doi.org/10.1172/JCI186711.
Copyright © 2026, Sesay et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published January 8, 2026 - Version history
View PDF
Abstract

MRE11, a breast tumor suppressor and component of the MRE11-RAD50-NBS1 (MRN) complex, plays a critical role in DNA end resection and initiation of ATM-dependent DNA damage signaling. However, the precise mechanisms governing MRE11 function in the DNA damage response (DDR) remain incompletely understood. Here, we found that MRE11 is deacetylated by the SIRT2 sirtuin deacetylase and breast tumor suppressor, which promotes DNA binding to facilitate DNA end resection and ATM-dependent signaling. SIRT2 deacetylase activity promoted DNA end resection. SIRT2 further complexed with and deacetylated MRE11 at conserved lysine (K) 393 in response to DNA double-strand breaks (DSBs), which promoted MRE11 localization and DNA binding at DSBs but not interaction with RAD50, NBS1, or CtIP. Moreover, MRE11 K393 deacetylation by SIRT2 promoted ATM-dependent signaling. Our findings define a mechanism regulating MRE11 binding to DNA through SIRT2 deacetylation, elucidating a critical upstream signaling event directing MRE11 function in the DDR and providing insight into how SIRT2 dysregulation leads to genomic instability and tumorigenesis.

Graphical Abstract
graphical abstract
Supplemental material

View Unedited blot and gel images

View

Version history
  • Version 1 (January 8, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts